BSX Stock Dips in Premarket Trading Despite Q4 Earnings, Revenue BeatZacks Investment Research • 02/04/26
Boston Scientific (BSX) Reports Q4 Earnings: What Key Metrics Have to SayZacks Investment Research • 02/04/26
Boston Scientific Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate AnalystsBenzinga • 02/04/26
4 Medical Product Stocks to Watch From a Challenging Industry (Revised)Zacks Investment Research • 02/03/26
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)GlobeNewsWire • 02/02/26
Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 01/30/26
Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings?Zacks Investment Research • 01/28/26
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to ConsiderZacks Investment Research • 01/24/26
Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio ActivitySeeking Alpha • 01/22/26
Down 6.3% in 4 Weeks, Here's Why Boston Scientific (BSX) Looks Ripe for a TurnaroundZacks Investment Research • 01/16/26
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)GlobeNewsWire • 01/15/26
BSX Stock May Gain From Newly Inked Deal to Buy Valencia TechnologiesZacks Investment Research • 01/15/26